The Carlat Psychiatry Podcast

Beverly Stoute, MD, shares research on the origins of unconscious racial bias.

CME: Take the CME Post-Test for this Episode

Published On: 07/22/2024

Duration: 11 minutes, 12 second

Chris Aiken, MD, Beverly Stoute, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

We talk with Beverly Stoute, MD, about how unconscious racial biases play out between therapist and patient.

CME: Take the CME Post-Test for this Episode

Published On: 07/15/2024

Duration: 16 minutes, 40 second

Chris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Kyle Greenway developed the Montreal Model to pair ketamine with psychotherapy. In this 3-part series, he shows us how to do it.

CME: Take the CME Post-Test for this Episode

Published On: 07/08/2024

Duration: 23 minutes, 38 second

Chris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Kyle Greenway developed the Montreal Model to pair ketamine with psychotherapy. In this 3-part series, he shows us how to do it.

CME: Take the CME Post-Test for this Episode

Published On: 07/01/2024

Duration: 18 minutes, 55 second

Chris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Kyle Greenway developed the Montreal Model to pair ketamine with psychotherapy. In this 3-part series, he shows us how to do it.

CME: Take the CME Post-Test for this Episode

Published On: 06/24/2024

Duration: 19 minutes, 13 second

Chris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

An FDA panel just rejected MDMA assisted therapy. We look at the reasons why, and what this means for the future of psychedelic therapy. 

CME: Take the CME Post-Test for this Episode

Published On: 06/17/2024

Duration: 25 minutes, 59 second

Chris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Did boundary violations sink MDMA assisted psychotherapy? We explore the reasons behind the FDA panel’s rejection of this psychedelic therapy.

CME: Take the CME Post-Test for this Episode

Published On: 06/10/2024

Duration: 20 minutes, 01 second

Chris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

In today's episode, Dr. DePhilippis tells us all about Contingency Management: what it is, how it works, and its evidence for the treatment of stimulant use disorders.

CME: Take the CME Post-Test for this Episode

Published On: 06/03/2024

Duration: 43 minutes, 29 second

Noah Capurso, MD, Dominick DePhilippis, MD have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Clinicians who have lived with mental illness share how it impaired them - and strengthened

them - on the job.

CME: Take the CME Post-Test for this Episode

Published On: 05/27/2024

Duration: 21 minutes, 50 second

Chris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

As we delved into Carl Jung's archetype of the wounded healer last Monday, it reminded us of something we learned about the serotonin transporter gene. Has modern genetics discovered a pathway to the archetype? You be the judge in this throwback to a 2021 episode. 

CME: Take the CME Post-Test for this Episode

Published On: 05/20/2024

Duration: 22 minutes, 31 second

Chris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.